Jason Goslin, Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 707 Haddonfield Berlin Rd Ste 101, Voorhees, NJ 08043 Phone: 856-857-6920 |
Colleen Mary Dykeman, Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 705 Haddonfield Berlin Rd, Voorhees, NJ 08043 Phone: 856-679-0537 |
Ms. Kristina Lee Matthews, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 707 Haddonfield Berlin Rd, Voorhees, NJ 08043 Phone: 856-857-6920 |
Sona Prajapati, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1302 Roberts Way, Voorhees, NJ 08043 Phone: 609-280-4382 |
News Archive
Ferring Pharmaceuticals and Roche have announced a collaboration to combine diagnostic testing technology from Roche with Ferring's human cell line derived recombinant follicle-stimulating hormone (human rFSH), a gonadotrophin currently in phase III development.
A kinase is a type of enzyme the body uses to regulate the functions of the proteins required for cell growth and maintenance, and researchers have discovered that one in particular plays a key role in developing prostate cancer. "It's known as Mnk, and although it appears not to be essential for normal cell maintenance, it's important for cancer growth" said Dr. Luc Furic, a postdoctoral researcher working with Dr. Nahum Sonenberg at McGill University's Goodman Cancer Research Centre and Department of Biochemistry.
3M Health Care and Zargis Medical, a majority-owned subsidiary of Speedus Corp. (Nasdaq:SPDE), announced today that the 3M™ Littmann® Electronic Stethoscope Model 3200 with Zargis Cardioscan™ software was named Popular Science's "Innovation of the Year." This prestigious honor, part of the publication's annual "Best of What's New Awards," highlights outstanding innovation, vision and execution in technologic, scientific and medical advances for the year.
A team of researchers led by cardiologists at UT Southwestern Medical Center has developed a new online tool to more accurately predict who among those ages 40-65 is at the highest risk of suffering a heart attack or stroke in the next 10 years.
Research led by the Centenary Institute has found that a compound extracted from a commonly cultivated orchid could be a potential new treatment option for prostate cancer.
› Verified 1 days ago